SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / General: lecanemab

general 1,737 words KG: Lecanemab

Contents

lecanemab

Knowledge Graph

Related Hypotheses (30)

SASP-Mediated Complement Cascade Amplification
Score: 0.70 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61 Multi-Modal Stress Response Harmonization
Score: 0.60

Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Ferroptosis Inhibition for α-Synuclein Neuroprotection
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Phase-Separated Organelle Targeting
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51 Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51 Senescence-Associated Myelin Lipid Remodeling
Score: 0.51 Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.50 Early Proteasome Restoration Therapy
Score: 0.50 Autophagosome Maturation Checkpoint Control
Score: 0.49 Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.49 cGAS-STING Senescence Circuit Disruption
Score: 0.49 White Matter Oligodendrocyte Protection via CXCL10 Inhibitio
Score: 0.48 Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.48

Related Analyses (20)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived

Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived

Related Experiments (5)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40 Real-world safety study of Lecanemab in Japanese AD patients
clinical · proposed · Score: 0.95 Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.40 Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.40 Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40

See Also (5)

Aducanumab (Aduhelm)
therapeutic · KG edge: targets Dementia Australia
institution · KG edge: therapeutic_target Alzheimer Indonesia
institution · KG edge: treats APOE contributes to Alzheimer's disease by regulating b
hypothesis · KG edge: therapeutic_target Amyloid-Related Imaging Abnormalities (ARIA)
entity · KG edge: implicated_in

Knowledge Graph (12 edges)

Lecanemab treats Early-Stage Alzheimer's Disease

Lecanemab associated_with Amyloid-Beta Clearance

Lecanemab targets Brain Amyloid Pathology

Lecanemab causes Amyloid Related Imaging Abnormalities

Lecanemab causes Microhemorrhages

Lecanemab causes Infusion Reactions

Lecanemab causes Macrohemorrhages

Lecanemab targets Amyloid-β

Lecanemab targets Amyloid Pathology

Lecanemab targets amyloid-β

SciDEX — scidex.ai — Dashboard | Atlas